125 related articles for article (PubMed ID: 25143360)
1. Prolactin determinants in healthy women: A large cross-sectional study within the EPIC cohort.
Tikk K; Sookthai D; Johnson T; Dossus L; Clavel-Chapelon F; Tjønneland A; Olsen A; Overvad K; Baglietto L; Rinaldi S; Romieu I; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Buckland G; Sánchez S; Molina-Montes E; Amiano P; Castaño JM; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Idahl A; Lundin E; Weiderpass E; Lund E; Waaseth M; Khaw KT; Key TJ; Travis RC; Gunter MJ; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2532-42. PubMed ID: 25143360
[TBL] [Abstract][Full Text] [Related]
2. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
Eliassen AH; Tworoger SS; Hankinson SE
Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
[TBL] [Abstract][Full Text] [Related]
3. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
Tikk K; Sookthai D; Fortner RT; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Ricceri F; Mattiello A; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Andresson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Merritt MA; Riboli E; Dossus L; Kaaks R
Breast Cancer Res; 2015 Mar; 17(1):49. PubMed ID: 25887963
[TBL] [Abstract][Full Text] [Related]
4. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
Tikk K; Sookthai D; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Rosso S; Panico S; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Huerta Castaño JM; Ardanaz E; Bueno-de-Mesquita HB; Monninkhof E; Onland-Moret C; Andersson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Gunter MJ; Riboli E; Dossus L; Kaaks R
Ann Oncol; 2014 Jul; 25(7):1422-1428. PubMed ID: 24718887
[TBL] [Abstract][Full Text] [Related]
5. Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland.
Faupel-Badger JM; Sherman ME; Garcia-Closas M; Gaudet MM; Falk RT; Andaya A; Pfeiffer RM; Yang XR; Lissowska J; Brinton LA; Peplonska B; Vonderhaar BK; Figueroa JD
Br J Cancer; 2010 Sep; 103(7):1097-102. PubMed ID: 20736944
[TBL] [Abstract][Full Text] [Related]
6. Association between lifestyle, dietary, reproductive, and anthropometric factors and circulating 27-hydroxycholesterol in EPIC-Heidelberg.
Le Cornet C; Johnson TS; Lu DL; Kaaks R; Fortner RT
Cancer Causes Control; 2020 Feb; 31(2):181-192. PubMed ID: 31938951
[TBL] [Abstract][Full Text] [Related]
7. Circulating prolactin levels and risk of epithelial ovarian cancer.
Clendenen TV; Arslan AA; Lokshin AE; Liu M; Lundin E; Koenig KL; Berrino F; Hallmans G; Idahl A; Krogh V; Lukanova A; Marrangoni A; Muti P; Nolen BM; Ohlson N; Shore RE; Sieri S; Zeleniuch-Jacquotte A
Cancer Causes Control; 2013 Apr; 24(4):741-8. PubMed ID: 23378139
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States).
Hankinson SE; Colditz GA; Hunter DJ; Manson JE; Willett WC; Stampfer MJ; Longcope C; Speizer FE
Cancer Causes Control; 1995 May; 6(3):217-24. PubMed ID: 7612801
[TBL] [Abstract][Full Text] [Related]
9. Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies.
Rice MS; Tworoger SS; Bertrand KA; Hankinson SE; Rosner BA; Feeney YB; Clevenger CV; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(1):245-53. PubMed ID: 25503962
[TBL] [Abstract][Full Text] [Related]
10. Plasma hormones in parous, nulliparous and postmenopausal Japanese women.
Hill P; Garbaczewski L; Kasumi K; Wynder EL
Cancer Lett; 1986 Nov; 33(2):131-6. PubMed ID: 3098404
[TBL] [Abstract][Full Text] [Related]
11. 24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment.
Kalleinen N; Polo-Kantola P; Irjala K; Porkka-Heiskanen T; Vahlberg T; Virkki A; Polo O
J Clin Endocrinol Metab; 2008 May; 93(5):1655-61. PubMed ID: 18319308
[TBL] [Abstract][Full Text] [Related]
12. Bioactive prolactin levels and risk of breast cancer: a nested case-control study.
Tworoger SS; Rice MS; Rosner BA; Feeney YB; Clevenger CV; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):73-80. PubMed ID: 25315962
[TBL] [Abstract][Full Text] [Related]
13. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
Nyante SJ; Faupel-Badger JM; Sherman ME; Pfeiffer RM; Gaudet MM; Falk RT; Andaya AA; Lissowska J; Brinton LA; Peplonska B; Vonderhaar BK; Chanock S; Garcia-Closas M; Figueroa JD
Breast Cancer Res; 2011 Apr; 13(2):R42. PubMed ID: 21470416
[TBL] [Abstract][Full Text] [Related]
15. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.
Hankinson SE; Willett WC; Michaud DS; Manson JE; Colditz GA; Longcope C; Rosner B; Speizer FE
J Natl Cancer Inst; 1999 Apr; 91(7):629-34. PubMed ID: 10203283
[TBL] [Abstract][Full Text] [Related]
16. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women.
Hankinson SE; Willett WC; Manson JE; Hunter DJ; Colditz GA; Stampfer MJ; Longcope C; Speizer FE
J Natl Cancer Inst; 1995 Sep; 87(17):1297-302. PubMed ID: 7658481
[TBL] [Abstract][Full Text] [Related]
17. Prolactin and breast cancer etiology: an epidemiologic perspective.
Tworoger SS; Hankinson SE
J Mammary Gland Biol Neoplasia; 2008 Mar; 13(1):41-53. PubMed ID: 18246319
[TBL] [Abstract][Full Text] [Related]
18. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
19. Rotating night shift work, sleep quality, selected lifestyle factors and prolactin concentration in nurses and midwives.
Bukowska A; Sobala W; Peplonska B
Chronobiol Int; 2015 Apr; 32(3):318-26. PubMed ID: 25364814
[TBL] [Abstract][Full Text] [Related]
20. Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer.
Gabrielson M; Ubhayasekera K; Ek B; Andersson Franko M; Eriksson M; Czene K; Bergquist J; Hall P
JNCI Cancer Spectr; 2018 Oct; 2(4):pky055. PubMed ID: 31360875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
